Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International

Wikipedia Affiliate Button

Home > Press > Arrowhead Pharmaceuticals Announces Retirement of COO Bruce Given

Abstract:
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced the retirement of Bruce Given, M.D., Arrowhead’s chief operating officer and head of R&D, which was previously planned and disclosed, after a more than 30-year career in biotechnology and pharmaceutical research, development, and sales and marketing. Dr. Given’s areas of responsibility have been assumed by Javier San Martin, M.D., chief medical officer, Curt Bradshaw, Ph.D., chief scientific officer, and James Hassard, chief commercial officer, all of whom report directly to Chris Anzalone, Ph.D., president and chief executive officer. Dr. Given will be retained in an advisory capacity for a period of at least one year.

Arrowhead Pharmaceuticals Announces Retirement of COO Bruce Given

Pasadena. CA | Posted on May 1st, 2020

Dr. Anzalone said: “Bruce had an impressive and successful career and Arrowhead benefited enormously from his leadership of our R&D organization since 2011. Together with the rest of the Arrowhead team, I would like to thank Bruce and wish him our best during his retirement.”

####

About Arrowhead Pharmaceuticals, Inc.
Arrowhead Pharmaceuticals develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep, and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Arrowhead’s RNAi-based therapeutics leverage this natural pathway of gene silencing.

For more information, please visit www.arrowheadpharma.com, or follow us on Twitter @ArrowheadPharma. To be added to the Company's email list and receive news directly, please visit http://ir.arrowheadpharma.com/email-alerts .

Safe Harbor Statement under the Private Securities Litigation Reform Act:

This news release contains forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. These statements are based upon our current expectations and speak only as of the date hereof. Our actual results may differ materially and adversely from those expressed in any forward-looking statements as a result of various factors and uncertainties, including the safety and efficacy of our product candidates, the duration and impact of regulatory delays in our clinical programs, our ability to finance our operations, the likelihood and timing of the receipt of future milestone and licensing fees, the future success of our scientific studies, our ability to successfully develop and commercialize drug candidates, the timing for starting and completing clinical trials, rapid technological change in our markets, and the enforcement of our intellectual property rights. Our most recent Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Q discuss some of the important risk factors that may affect our business, results of operations and financial condition. We assume no obligation to update or revise forward-looking statements to reflect new events or circumstances.

For more information, please click here

Contacts:
Arrowhead Pharmaceuticals, Inc.
Vince Anzalone, CFA
626-304-3400


Investors and Media:
LifeSci Advisors, LLC
Brian Ritchie
212-915-2578

www.lifesciadvisors.com

Copyright © Arrowhead Pharmaceuticals, Inc.

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

NUS researchers develop stretchable, self-healing and illuminating material for ‘invincible’ light-emitting devices: Promising applications include damage-proof flexible display screens and illuminating electronic skin for autonomous soft robots May 31st, 2020

The concept of creating «brain-on-chip» revealed: A team of scientists is working to create brain-like memristive systems providing the highest degree of adaptability for implementing compact and efficient neural interfaces, new-generation robotics, artificial intelligence, perso May 29th, 2020

SUTD developed a simple method to print planar microstructures of polysiloxane: The new method, embedded ink writing (EIW), enables direct writing of polysiloxane which helps in the fabrication of microfluidic devices, flexible wearables, and soft actuators May 29th, 2020

Researchers develop experimental rapid COVID-19 test using nanoparticle technique: Advanced nanotechnology provides 'naked eye' visual detection of virus in 10 minutes May 29th, 2020

Nanomedicine

The concept of creating «brain-on-chip» revealed: A team of scientists is working to create brain-like memristive systems providing the highest degree of adaptability for implementing compact and efficient neural interfaces, new-generation robotics, artificial intelligence, perso May 29th, 2020

Researchers develop experimental rapid COVID-19 test using nanoparticle technique: Advanced nanotechnology provides 'naked eye' visual detection of virus in 10 minutes May 29th, 2020

2D sandwich sees molecules with clarity: Rice University engineers adapt 2D ‘sandwich’ for surface-enhanced Raman spectroscopy May 15th, 2020

Twisting 2D materials uncovers their superpowers: Researchers have developed a completely new method for twisting atomically thin materials, paving the way for applications of 'twistronics' based on tunable 2D materials May 12th, 2020

Announcements

NUS researchers develop stretchable, self-healing and illuminating material for ‘invincible’ light-emitting devices: Promising applications include damage-proof flexible display screens and illuminating electronic skin for autonomous soft robots May 31st, 2020

Configurable circuit technology poised to expand silicon photonic applications: Chips can be programmed after fabrication for use in communication, computing or biomedical applications May 29th, 2020

SUTD developed a simple method to print planar microstructures of polysiloxane: The new method, embedded ink writing (EIW), enables direct writing of polysiloxane which helps in the fabrication of microfluidic devices, flexible wearables, and soft actuators May 29th, 2020

Researchers develop experimental rapid COVID-19 test using nanoparticle technique: Advanced nanotechnology provides 'naked eye' visual detection of virus in 10 minutes May 29th, 2020

Appointments/Promotions/New hires/Resignations/Deaths

Nexeon Appoints New Chairman May 18th, 2020

The National Space Society Mourns the Passing of Astronaut Al Worden: Worden flew as the Command Module Pilot on Apollo 15 March 19th, 2020

The National Space Society Mourns the Passing of Freeman Dyson: Long-Serving Member of the NSS Board of Governors and Recipient of the Robert A. Heinlein and Gerard K. O’Neill Memorial Awards February 28th, 2020

Nano Dimension Appoints Seasoned Hi-Tech Executive Yaron Eitan to its Board of Directors February 13th, 2020

Nanobiotechnology

The concept of creating «brain-on-chip» revealed: A team of scientists is working to create brain-like memristive systems providing the highest degree of adaptability for implementing compact and efficient neural interfaces, new-generation robotics, artificial intelligence, perso May 29th, 2020

Researchers develop experimental rapid COVID-19 test using nanoparticle technique: Advanced nanotechnology provides 'naked eye' visual detection of virus in 10 minutes May 29th, 2020

2D sandwich sees molecules with clarity: Rice University engineers adapt 2D ‘sandwich’ for surface-enhanced Raman spectroscopy May 15th, 2020

Chemistry breakthrough could speed up drug development: Scientists have successfully developed a new technique to reliably grow crystals of organic soluble molecules from nanoscale droplets, unlocking the potential of accelerated new drug development May 8th, 2020

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project